Oncap 20 mg (zastaprazan citric acid salt)

Adult dose

This medicine is administered to adults as follows. It may be taken with or without food. 1. Treatment of erosive gastroesophageal reflux disease - Administer 20 mg orally once daily for 4 weeks. If the condition is not resolved, continue treatment for an additional 4 weeks. 2. Treatment of gastric ulcers - Administer 20 mg orally once daily for up to 8 weeks.

This medication should not be used in patients who have had an allergic reaction to this drug or any of its components. Additionally, it should not be administered to patients taking certain antiviral drugs such as atazanavir, nelfinavir, or rilpivirine. Pregnant or breastfeeding women should not take this medication. This drug contains lactose, so it should not be used in patients with a genetic problem that prevents the digestion of lactose. Safety has not been established for patients with liver or kidney problems, so it should be used cautiously in these patients. Elderly patients may have decreased bodily function, so caution is advised when taking it. Taking this medication may cause various gastrointestinal side effects, along with reports of headaches, muscle pain, and skin rashes among other adverse reactions. Furthermore, since this medication suppresses gastric acid, there may be an increased risk of infections and an increased risk of fractures related to osteoporosis with long-term use. Patients on long-term treatment may experience decreased magnesium levels in the blood, so regular tests are necessary. Vitamin B12 deficiency may occur, so caution is needed during long-term use. This medication may interact with other drugs, so special care should be taken, especially when taken with certain antiviral drugs, antibiotics, or anti-inflammatory painkillers. Pregnant or breastfeeding women should avoid this medication, and breastfeeding should be discontinued if taking it. Safety for children and adolescents has not been sufficiently verified, so caution is required in usage. No specific toxic symptoms have been reported in case of overdose, but patient condition should be closely monitored and appropriate treatment should be conducted if needed. This medication should be kept out of reach of children, and care should be taken not to transfer it to another container as this could affect quality.

• Hiatal hernia
• dyspepsia
• chronic gastritis
• erosive gastritis
• nausea
• abdominal distension
• diarrhea
• duodenal polyps
• discomfort in the upper abdomen
• bloating

This medication should be stored in a sealed container to protect it from air and moisture, and it is recommended to keep it at room temperature between 1°C and 30°C. Proper temperature and container storage will help maintain the effect of the medication for a longer period.

Appearance

pink round film-coated tablet

Package unit

28 tablets/bottle, 7 tablets/bottle, 300 tablets/bottle